drugset / Trial / NCT00353561

Diabetes Mellitus and Vulvovaginal Candidiasis

NCT00353561

Phase 3 Completed 100 enrolled Indian Council of Medical Research
RandomizedParallel-groupOpen-labelTreatment

Summary

Clinical and mycological response to oral fluconazole and boric acid suppositories was assessed in patients with diabetes mellitus and vulvovaginal candidiasis.

Timeline

Start
2004-06
Primary completion
2006-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Boric acid Small molecule 600 mg Other
Subject Fluconazole Small molecule 150 mg Oral